EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor Electric Field Therapy Inhibits TGF ‐β/ C 1 R Signaling Axis‐Driven Epithelial‐Mesenchymal Transition in Glioblastoma

Junyi Chen iD, Yuyang Liu iD, Qi Liu iD, Hongyu Liu iD, Cheng Sun, Xu Chen, Xinchen Zhao, Jinxin Lan iD, Yaping Feng, Lilin Qin, Jialin Liu, Ze Li iD und 1 weitere

CNS Neuroscience & Therapeutics · 2026

DOI: 10.1002/cns.70738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2026. Verfasst von Junyi Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Chinese PLA, Beijing, China. Hauptthemen laut MEDLINE: Glioblastoma, Epithelial-Mesenchymal Transition, Brain Neoplasms, Transforming Growth Factor beta. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma (GBM) is one of the most aggressive and treatment‐resistant primary brain tumors, with the mesenchymal subtype exhibiting particularly poor prognosis. Tumor electric field therapy (TEFT) has emerged as a promising adjunctive treatment, but its underlying molecular mechanisms remain incompletely understood.

Methods

GBM functional states were analyzed using CancerSEA datasets. GBM cell lines were treated with 200 kHz TEFT at 2.2 V/m for 72 h. C1R was knocked down using siRNA and shRNA. Cell morphology, migration, invasion, proliferation, and signaling pathways were assessed through various assays. Findings were validated in animal models and clinical specimens.

Results

C1R was identified at the intersection of TEFT‐downregulated genes, poor prognosis markers, and functional state genes. C1R was significantly upregulated in mesenchymal GBM and strongly correlated with epithelial‐mesenchymal transition (EMT). Single‐cell RNA sequencing revealed C1R was predominantly expressed in MES‐like malignant cells with high EMT signature scores. TEFT treatment induced morphological changes from elongated spindle‐shaped to rounded epithelial‐like morphology, increased E‐cadherin expression, and decreased mesenchymal markers (N‐cadherin, Vimentin, YKL‐40). Mechanistically, TEFT suppressed the TGF‐β/SMAD2/3/STAT3 signaling pathway, downregulating C1R expression. C1R knockdown significantly reduced tumor growth in vivo, while exogenous TGF‐β restored C1R expression and reversed the mesenchymal phenotype in a dose‐ and time‐dependent manner.

Conclusion

TEFT inhibits GBM progression by suppressing the TGF‐β/SMAD2/3/STAT3/C1R axis, thereby attenuating EMT and reducing tumor aggressiveness. These findings uncover a novel mechanism of TEFT and identify C1R as a potential biomarker and therapeutic target for GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaEpithelial-Mesenchymal TransitionBrain NeoplasmsTransforming Growth Factor betaElectric Stimulation TherapyHumansAnimalsSignal TransductionCell Line, TumorMiceMice, NudeXenograft Model Antitumor Assays

Stichwörter der Autor:innen

EMTTGF‐β signaling pathwaycomplement C1Rglioblastomamesenchymal subtypetumor electric field therapy

Substanzen

Transforming Growth Factor beta

Autor:innen und Institutionen

  • Medical School of Chinese PLA, Beijing, China.
  • Department of Neurosurgery, Chinese PLA General Hospital, Beijing, China.
  • Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
  • Department of Neurosurgery, 920th Hospital of Joint Logistics Support Force, Kunming, China.
  • Graduate School, Kunming Medical University, Kunming, China.
  • Faculty of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, Beijing, China.

ORCID-Profile: Junyi Chen, Yuyang Liu, Qi Liu, Hongyu Liu, Jinxin Lan, Ze Li, Ling Chen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, J., Liu, Y., Liu, Q., Liu, H., Sun, C., Chen, X., Zhao, X., Lan, J., Feng, Y., Qin, L., Liu, J., Li, Z., & Chen, L. (2026). Tumor Electric Field Therapy Inhibits TGF ‐β/ C 1 R Signaling Axis‐Driven Epithelial‐Mesenchymal Transition in Glioblastoma. CNS Neuroscience & Therapeutics. https://doi.org/10.1002/cns.70738

Vancouver

Chen J, Liu Y, Liu Q, Liu H, Sun C, Chen X, et al. Tumor Electric Field Therapy Inhibits TGF ‐β/ C 1 R Signaling Axis‐Driven Epithelial‐Mesenchymal Transition in Glioblastoma. CNS Neuroscience & Therapeutics. 2026. doi:10.1002/cns.70738

BibTeX
@article{Chen2026,
  author = {Chen, Junyi and Liu, Yuyang and Liu, Qi and Liu, Hongyu and Sun, Cheng and Chen, Xu and Zhao, Xinchen and Lan, Jinxin and Feng, Yaping and Qin, Lilin and Liu, Jialin and Li, Ze and Chen, Ling},
  title = {Tumor Electric Field Therapy Inhibits TGF ‐β/ C 1 R Signaling Axis‐Driven Epithelial‐Mesenchymal Transition in Glioblastoma},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  doi = {10.1002/cns.70738}
}
Kostenlos starten →